MABTECH INC

MABTECH INC specializes in the manufacturing of biological products, with demonstrated expertise in developing and producing specialized immunoassay reagents for research and diagnostic applications. Their recent work on the FLUOROSPOT PLUS MONKEY IFN-γ assay highlights advanced capabilities in cytokine detection systems, flow cytometry-compatible reagent formulation, and non-human primate immunology tools. The company applies precise biological manufacturing protocols to produce high-sensitivity, reproducible reagents used in cellular immune response analysis, particularly in preclinical vaccine and therapeutic development. Their technical focus includes fluorescence-based detection platforms, monoclonal antibody conjugation, and standardized assay optimization for regulatory-compliant production environments. MABTECH INC has delivered critical biological reagents to the Department of Health and Human Services, supporting research initiatives in infectious disease and immunology. Their engagement with HHS reflects a niche role in supplying specialized assay components for government-funded biomedical studies, likely serving agencies such as NIH or CDC through contracted production of research-grade reagents. The relationship suggests a trusted vendor status for complex, low-volume biological manufacturing needs requiring stringent quality control. The contractor’s primary industry focus is biological product manufacturing (NAICS 325414), a vertical centered on the production of non-diagnostic biological substances such as cytokines, antibodies, and cell-based reagents. MABTECH positions itself as a specialized supplier to the biomedical research sector, serving laboratories and institutions requiring validated, GMP-aligned reagents for immunological studies. Their market niche lies in supporting translational research with custom-tailored biological tools. MABTECH INC is a small, privately held entity based in Cincinnati, Ohio, with no federal certifications on record. Operating as a 2L structure, the company maintains a focused, agile presence in the government bioresearch supply chain, serving specialized needs within the federal life sciences ecosystem without broad-scale manufacturing capacity.